Clinical and metabolomic predictors of regression to normoglycemia in a population at intermediate cardiometabolic risk

BACKGROUND: Impaired fasting glucose (IFG) is a prevalent and potentially reversible intermediate stage leading to type 2 diabetes that increases risk for cardiometabolic complications. The identification of clinical and molecular factors associated with the reversal, or regression, from IFG to a no...

Descripción completa

Detalles Bibliográficos
Autores principales: Sevilla-González, Magdalena del Rocío, Merino, Jordi, Moreno-Macias, Hortensia, Rojas-Martínez, Rosalba, Gómez-Velasco, Donají Verónica, Manning, Alisa K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7916268/
https://www.ncbi.nlm.nih.gov/pubmed/33639941
http://dx.doi.org/10.1186/s12933-021-01246-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7916268/
https://www.ncbi.nlm.nih.gov/pubmed/33639941
http://dx.doi.org/10.1186/s12933-021-01246-1

Ejemplares similares